|
- Pioneering mRNA technology - Moderna
Learn how we’re changing the world of medicine Discover career opportunities, our product pipeline, and browse media resources Meet Moderna
- Our Story - Moderna
Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus
- mRNA medicines we are currently developing
Track the development of Moderna’s mRNA medicines From preclinical development to commercial phase
- Investor Relations - Moderna
Innovation Incubator New venture labs Terms of Use Site Map Privacy Policy Contact Moderna © 2025 Moderna, Inc
- Our Mission Values - Moderna
Our Values Moderna people hold a deep sense of responsibility for each other, patients, the environment and our local communities Our people live our Values every day
- Company Culture - Moderna
Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine
- Modernas mRNA Platform - Moderna
In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more
- News and Media – Moderna
Resources for journalists and media members The latest press releases by Moderna
|
|
|